CL100 expression is down-regulated in advanced epithelial ovarian cancer and its re-expression decreases its malignant potential
- 25 June 2002
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 21 (28) , 4435-4447
- https://doi.org/10.1038/sj.onc.1205542
Abstract
Although early stage ovarian cancer can be effectively treated with surgery and chemotherapy, the majority of cases present with advanced disease, which remains essentially incurable. Unfortunately, little is known about the genes important for the development and progression of this disease. In this study, the expression of 68 phosphatases was determined in immortalized ovarian epithelial cells (IOSE) and compared to ovarian cancer cell lines. CL100, a dual specificity phosphatase, displayed 10-25-fold higher expression in normal compared to malignant ovarian cell lines. Immunohistochemical staining of normal ovaries and 68 ovarian cancer specimens confirmed this differential expression. Re-expression of CL100 in ovarian cancer cells decreased adherent and non-adherent cell growth and induced phenotypic changes including loss of filopodia and lamellipodia with an associated decrease in cell motility. Induced expression of CL100 in ovarian cancer cells suppressed intraperitoneal tumor growth in nude mice. These results show for the first time that CL100 expression is altered in human ovarian cancer, that CL100 expression changes cell morphology and motility, and that it suppresses intraperitoneal growth of human ovarian epithelial cancer. These data suggest that down-regulation of CL100 may play a role in the progression of human ovarian cancer.Keywords
This publication has 25 references indexed in Scilit:
- Cancer Statistics, 2001CA: A Cancer Journal for Clinicians, 2001
- Protein Kinase C-ζ and Phosphoinositide-dependent Protein Kinase-1 Are Required for Insulin-induced Activation of ERK in Rat AdipocytesPublished by Elsevier ,1999
- Constitutive activation of the 41-/43-kDa mitogen-activated protein kinase signaling pathway in human tumorsOncogene, 1999
- From Form to Function: Signaling by Protein Tyrosine PhosphatasesCell, 1996
- Transfection of Human Ovarian Cancer Cells with the HER-2/neuReceptor Tyrosine Kinase Induces a Selective Increase in PTP-H1, PTP-1B, and PTP-α ExpressionGynecologic Oncology, 1996
- Inactivation of p42 MAP kinase by protein phosphatase 2A and a protein tyrosine phosphatase, but not CL100, in various cell linesCurrent Biology, 1995
- Inhibition of Ras-Induced DNA Synthesis by Expression of the Phosphatase MKP-1Science, 1994
- Rapid deactivation of MAP kinase in PC12 cells occurs independently of induction of phosphatase MKP‐1FEBS Letters, 1994
- Oxidative stress and heat shock induce a human gene encoding a protein-tyrosine phosphataseNature, 1992
- Protein Tyrosine Phosphatases: A Diverse Family of Intracellular and Transmembrane EnzymesScience, 1991